Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gordon Daniel

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Schizophrenia Research|August 1, 2013
Issues in selection of instruments to measure negative symptomsDavid Gordon Daniel
JAACAP Open|June 16, 2025
Replicating and Extending the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric TrialsEric A Youngstrom, Joshua A Langfus, David Gordon Daniel, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 16, 2022
An Optimized Version of the Positive and Negative Symptoms Scale (PANSS) for Pediatric TrialsRobert L Findling, Eric A Youngstrom, Jon M McClellan, et al.
Schizophrenia Bulletin Open|November 6, 2024
Rationale and Challenges for a New Instrument for Remote Measurement of Negative SymptomsDavid Gordon Daniel, Alex S Cohen, Philip D Harvey, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Schizophrenia Research|August 1, 2013
Issues in selection of instruments to measure negative symptomsDavid Gordon Daniel
JAACAP Open|June 16, 2025
Replicating and Extending the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric TrialsEric A Youngstrom, Joshua A Langfus, David Gordon Daniel, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 16, 2022
An Optimized Version of the Positive and Negative Symptoms Scale (PANSS) for Pediatric TrialsRobert L Findling, Eric A Youngstrom, Jon M McClellan, et al.
Schizophrenia Bulletin Open|November 6, 2024
Rationale and Challenges for a New Instrument for Remote Measurement of Negative SymptomsDavid Gordon Daniel, Alex S Cohen, Philip D Harvey, et al.
Pageof 1